22-24 April 2022
Hilton Antwerp Old Town, Antwerp, Belgium
2022 IKCS: Europe Hybrid Meeting Platform and
On-Demand Content is now available!
Thank you for attending 2022 IKCS: Europe!
Session topics include:
- Award Lectures- Urology and Oncology
- Basic Science in RCC
- Biomarkers in RCC
- Diagnostics and Screening
- Keynote Lecture
- Oral Abstract Session
- Patient Considerations
- The Role of Radiation Therapy in the Management of RCC
- Selecting Therapy for non-clear cell RCC Subtypes
- Surgical Approaches in Kidney Cancer
- Systemic Therapy: Selecting First-line Therapy and Later-line Therapy
- Therapeutic Management
- WoodFire (WoodFire is an exciting chance to watch clinicians debate the various treatment options for presented oncology cases. It’s the fiercest tumor board you’ll ever see!)
The 2022 Program will also feature in-person and virtual networking opportunities including:
- Meet the Experts Networking
- Women in Renal Cell Carcinoma Networking
- Dedicated Poster Sessions and Guided Poster Walks
- Exhibit Hall
- Receptions and more!
Continuing Medical Education (CME) Information
Jointly provided by The France Foundation and the Kidney Cancer Association.
Target Audience: This educational activity is intended for medical oncologists and urologists who treat patients with kidney cancer. Fellows, trainees, nurses, nurse practitioners, physician assistants, and other healthcare professionals involved in the management of kidney cancer are invited to participate.
Statement of Need: Education and interaction surrounding the space of renal cell carcinoma are paramount to improving patient care. This program is targeted to physicians, advocates, researchers, and care team members to help promote learning and collaboration for advancement in the renal cancer space.
Educational Learning Activity Objectives: Upon completion of this course, the participants should be able to:
- Characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma
- Identify the novel approaches to non-clear RCC patient management
- Understand the role of the tumor microenvironment in kidney cancer
- Discuss how to design biomarker driven clinical trials in kidney cancer
Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The France Foundation and the Kidney Cancer Association. The France Foundation is accredited by ACCME to provide continuing medical education for physicians.
Physicians: The France Foundation designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The 2022 IKCS: Europe – International Kidney Cancer Symposium, Antwerp, Belgium, 22/04/2022- 24/04/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 14 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama–assn.org/education/earn–credit–participation–international–activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
IKCS: Europe Scientific Program Committee
Thank you to our 2022 IKCS: Europe Planners!
Review the important dates below for 2022 IKCS: Europe
|Abstract Submissions Open||Mid-December 2021|
|Program Details and Speakers Released||Early February 2022|
|Registration Now Open!||Now Open! Register Today!|
|Hotel Booking Open!||Now Open! Reserve Today!|
|Abstract Submission Deadline|
(all complete Regular, TPS, and Case Report submissions, and all LBA Placeholders due at this time)
Extended to February 9, 2022 at 23:59 GMT
|LBA Submission Deadline (LBA Placeholder required by February 9 deadline)||February 28, 2022 at 23:59 GMT (placeholder required by February 9, 2022)|
|Abstract Notifications Sent to Lead Authors||Late February 2022|
|Abstract Titles Released||Mid-March 2022|
|Abstract Withdrawal Deadline|
(Withdrawal requests must be submitted by the Lead Author to [email protected])
|March 11, 2022|
|Presentation Slides Due||March 16, 2022|
|Early Registration Deadline- REGISTER NOW||March 23, 2022 at 23:59 GMT|
|Poster Uploads Due||April 1, 2022|
|Abstracts Released||April 18, 2022 at 12:00 PM CDT|
|Meeting Dates||April 22, 2022- April 24, 2022|
Thank You to Our 2022 IKCS: Europe Sponsors!
Sponsorship and Exhibitor Opportunities
Download the 2022 IKCS: Europe Sponsorship Prospectus. Please contact [email protected] for more information.
2022 IKCS: Europe is rated COMPLIANT by Ethical MedTech e4ethics conference vetting system.
Registration and Hotel Information
Review Registration Rates and Categories below.
|Category||Early Registration Rate (Register by March 23, 2022 at 23:59 GMT)||Regular Registration Rate (After March 23, 2022)||Post-Event (April 25, 2022 to December 31, 2022)|
|Virtual Only Physician/Scientist||€300||€400|
|In-person Allied Health Professional||€260||€350|
|Virtual Only Allied Health Professional||€210||€280|
|In-person Physician In-Training||€260||€350|
|Virtual Only Physician In-Training||€210||€280|
|Virtual Only Patient/Advocate/Caregiver||Complimentary*||Complimentary*|
|Virtual Only Industry||€390||€520|
|Virtual Only Media||Complimentary**||Complimentary**|
|Post-Event On-Demand Access||N/A||N/A||€350|
**If you are a Media employee interested in attending 2022 IKCS: Europe, please contact [email protected] with your interest and plan for meeting coverage. This Registration category is reserved only for Media.